Neuropharmacological and Neurochemical Properties of N-(2-cyanoethyl)-2-phenylethylamine, a Prodrug of 2-phenylethylamine

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1987 Oct 1

PMID 2890391

Citations 12

Authors

G B Baker

R T Coutts

T S Rao

Affiliations

Soon will be listed here.

Abstract

1 N-(2-cyanoethyl)-2-phenylethylamine (CEPEA) was examined as a possible prodrug of 2-phenylethylamine (PEA). 2 Pharmacokinetics of PEA and CEPEA were investigated in rat brain, blood and liver by gas chromatography with electron-capture detection (GC-ECD). Interactions of PEA and CEPEA with putative neurotransmitter amines were investigated by use of high performance liquid chromatography with electrochemical detection (h.p.l.c.-e.c.). 3 Administration of PEA caused transient increases in PEA concentrations which decreased rapidly in brain and blood and at a slower rate in liver. Administration of CEPEA caused sustained elevations of PEA concentrations and elimination of PEA was markedly decreased in these tissues relative to the situation after administration of PEA itself. 4 Administration of CEPEA caused more prolonged decreases in brain noradrenaline, dopamine and 5-hydroxytryptamine concentrations than those observed after PEA administration, although values increased to control levels eventually.

Citing Articles

Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats.

Li Y, Li L, Stephens M, Zenner D, Murray K, Winship I J Neurophysiol. 2013; 111(1):145-63.

PMID: 24068759 PMC: 3921369. DOI: 10.1152/jn.00508.2013.

Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine.

Matveychuk D, Nunes E, Ullah N, Velazquez-Martinez C, MacKenzie E, Baker G J Neural Transm (Vienna). 2013; 120(6):987-96.

PMID: 23392617 DOI: 10.1007/s00702-013-0978-0.

Prodrugs for amines.

Simplicio A, Clancy J, Gilmer J Molecules. 2008; 13(3):519-47.

PMID: 18463563 PMC: 6245426. DOI: 10.3390/molecules13030519.

Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.

Masse F, Hascoet M, Dailly E, Bourin M Psychopharmacology (Berl). 2005; 183(4):471-81.

PMID: 16307296 DOI: 10.1007/s00213-005-0220-3.

Antidepressant-like effects in various mice strains in the forced swimming test.

David D, Renard C, Jolliet P, Hascoet M, Bourin M Psychopharmacology (Berl). 2003; 166(4):373-82.

PMID: 12601501 DOI: 10.1007/s00213-002-1335-4.

References

Wolf M, Mosnaim A . Phenylethylamine in neuropsychiatric disorders. Gen Pharmacol. 1983; 14(4):385-90. DOI: 10.1016/0306-3623(83)90020-4. View

Duncan J, Hallstrom G, Lindeke B, Cho A . Effects of alpha-carbon substituents on the N-demethylation of N-methyl-2-phenethylamines by rat liver microsomes. Drug Metab Dispos. 1983; 11(1):15-20. View

Philips S, Robson A . In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine. Neuropharmacology. 1983; 22(11):1297-301. DOI: 10.1016/0028-3908(83)90203-4. View

McQuade P, Wood P . The effects of beta-phenylethylamine on tyramine and dopamine metabolism. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(4-6):755-9. DOI: 10.1016/0278-5846(83)90060-x. View

Dyck L . The behavioural effects of phenelzine and phenylethylamine may be due to amine release. Brain Res Bull. 1984; 12(1):23-8. DOI: 10.1016/0361-9230(84)90210-7. View

Lundberg P, Oreland L, Engberg G . Inhibition of locus coeruleus neuronal activity by beta-phenylethylamine. Life Sci. 1985; 36(19):1889-96. DOI: 10.1016/0024-3205(85)90163-8. View

Suckling C, Breckenridge R, Bansal S, Williams L, Watling K, Iversen L . Non-selective inhibition of GABA and 5-HT uptake systems in rat brain by N-n-alkyl hydroxybenzylamine and N-n-alkyl phenylethylamine derivatives. Biochem Pharmacol. 1985; 34(23):4173-7. DOI: 10.1016/0006-2952(85)90213-8. View

Garcha G, Imrie P, Marley E, Thomas D . [14C]-beta-phenethylamine, its distribution after administration by various routes to cats, and the effects of monoamine oxidase inhibitors. Br J Pharmacol. 1985; 86(4):877-88. PMC: 1916635. DOI: 10.1111/j.1476-5381.1985.tb11110.x. View

Coutts R, Nazarali A, Baker G, Pasutto F . Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol. 1986; 64(6):724-8. DOI: 10.1139/y86-122. View

10.

Baker G, Rao T, Coutts R . Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization. J Chromatogr. 1986; 381(2):211-7. DOI: 10.1016/s0378-4347(00)83586-0. View

11.

Nazarali A, Baker G, Coutts R, Yeung J, Rao T . Rapid analysis of beta-phenylethylamine in tissues and body fluids utilizing pentafluorobenzoylation followed by electron-capture gas chromatography. Prog Neuropsychopharmacol Biol Psychiatry. 1987; 11(2-3):251-8. DOI: 10.1016/0278-5846(87)90068-6. View

12.

Rao T, Baker G, Coutts R . N-(3-chloropropyl)phenylethylamine as a possible prodrug of beta-phenylethylamine: studies in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry. 1987; 11(2-3):301-8. DOI: 10.1016/0278-5846(87)90074-1. View

13.

Nazarali A, Baker G, Coutts R, Wong T . N-(2-cyanoethyl)tranylcypromine, a potential prodrug of tranylcypromine: its disposition and interaction with catecholamine neurotransmitters in brain. Pharm Res. 1987; 4(1):16-20. DOI: 10.1023/a:1016417624741. View

14.

Wurtman R, Axelrod J . A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. Biochem Pharmacol. 1963; 12:1439-41. DOI: 10.1016/0006-2952(63)90215-6. View

15.

Dewhurst S . New theory of cerebral amine function and its clinical application. Nature. 1968; 218(5147):1130-3. DOI: 10.1038/2181130a0. View

16.

Fuxe K, Grobecker H, Jonsson J . The effect of beta-phenylethylamine on central and peripheral monoamine-containing neurons. Eur J Pharmacol. 1967; 2(3):202-7. DOI: 10.1016/0014-2999(67)90088-x. View

17.

Boulton A, Milward L . Separation, detection and quantitative analysis of urinary beta-phenylethylamine. J Chromatogr. 1971; 57(2):287-96. DOI: 10.1016/0021-9673(71)80042-0. View

18.

Jackson D . The effect of beta-phenethylamine on noradrenaline concentrations in guinea-pig brain. J Pharm Pharmacol. 1971; 23(8):623-4. DOI: 10.1111/j.2042-7158.1971.tb08728.x. View

19.

BECKETT A, Shenoy E, Salmon J . The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution and metabolism of (plus or minus)-ethylamphetamine in man. J Pharm Pharmacol. 1972; 24(3):194-202. DOI: 10.1111/j.2042-7158.1972.tb08964.x. View

20.

Boulton A, Philips S, Durden D . The analysis of certain amines in tissues and body fluids as their dansyl derivatives. J Chromatogr. 1973; 82(1):137-42. DOI: 10.1016/s0021-9673(01)80084-4. View